New Nasal Drug Delivery Device for Chronic Sinusitis Patients Now Available from ASL Pharmacy®

A new double barrel atomization device from ASL Pharmacy® offers hope for chronic sinusitis patients. The NasoNeb™ Nasal Nebulizer may be used for the administration of compounded tobramycin, clarithromycin, mupirocin, meropenem and other antibiotics, anti-fungals, mucolytics and corticosteroids.

Camarillo, CA (PRWEB) May 4, 2010 -- Chronic sinusitis patients have new hope for treatment with the release of a new drug delivery device from ASL Pharmacy®. Designed to administer compounded clarithromycin, liquid mupirocin, tobramycin, vancomycin, meropenem and other medications, the NasoNeb™ Nasal Nebulizer, manufactured by MedInvent, LLC, delivers a topical treatment by applying positive-pressure atomization towards the sinuses. The NasoNeb™ Nasal Nebulizer, an FDA listed medical device for nasal drug administration, utilizes the latest irrigation and atomization technologies to provide dual-nostril, positive-pressure medication deposition in less than two minutes, with minimal drug waste.

The device creates a low-volume irrigation effect with particles small enough to deposit medication to the right places, yet large enough to not enter the lungs or bronchioles. The NasoNeb™ Nasal Nebulizer may be prescribed by physicians when oral medications have failed or for patients who cannot tolerate oral medications.

"Patient compliance has been very high with this new device due to the short treatment time of only two minutes," states Russell Reitz, Pharm.D., Pharmacy Director for ASL®. "We have dispensed over 1,500 NasoNebs™ to patients thus far who are experiencing positive effects."

The NasoNeb™ Nasal Nebulizer allows the physician to efficiently perform maximal medical therapy on their patient. Recognizing new developments in medical therapy for chronic sinusitis, ASL® prepares and dispenses specialized compounded medications upon physician order to assist them in the management of difficult patient cases.

In the past when medications were combined, treatment time would also increase, meaning a patient could experience a 20-30 minute treatment. By combining the latest atomization and irrigation technologies, with the NasoNeb™, up to four medications may be mixed and administered in less than two minutes, something never before accomplished with a nasal nebulizer.

Sinus infections and allergies are common. It is estimated that 10 percent of the U.S. population (30 million-plus) suffer from chronic sinusitis caused by fungus, bacteria and/or allergens. About 400,000 of these patients receive sinus surgery for this disease annually. For many, chronic sinusitis is a debilitating, long-lasting experience. ASL Pharmacy's goal is to provide unique topical therapies not available commercially anywhere else with minimum bioavailability that assist physicians in managing sinus disease and help them improve each patient's quality of life.

"I have been having chronic sinus trouble for about 15 years," says one patient. "I have had surgery to remove nasal polyps six times. I typically get sinus infections about once a month. It seems I barely get done with an antibiotic before another infection sets in. I started using the NasoNeb™ system about six months ago. In that time, I have only had one sinus infection. And the NasoNeb™ took care of it before it got very bad. My sinus polyps have been reduced in size, and I am hopeful that I will not need any more surgeries. I would highly recommend this system to anyone who suffers with chronic sinus problems."

The dual-nostril, positive-pressure effect produced by the NasoNeb™ Nasal Nebulizer is similar to irrigation. An additional topical sinus therapy ASL® supports is sinus irrigations with the NeilMed® Sinus Rinse bottle, which is a single-nostril, positive-pressure device. The main difference between the squeeze bottle approach and the NasoNeb™ Nasal Nebulizer is that the NasoNeb™ atomizes low-volume saline and medications whereas the NeilMed® simply relies on liquid. All devices dispensed by ASL Pharmacy® are fast and easy. For topical sinus administration, ASL Pharmacy® only dispenses approved medical devices along with easy-to-use, pre-mixed, unit-dosed medication vials.

Another patient says: "I have had nasal and sinus problems for my entire life. I have used multiple antibiotics, nasal sprays, nebulizers, antihistamines, allergy therapy, decongestants and I have had five sinus surgeries…After three weeks on the NasoNeb™ with mometasone, I am 100 percent improved!"

ASL® focuses on preparing specialized compounds for the treatment of chronic sinusitis. Working with ENTs, allergists and other physicians who treat CRS, ASL® has helped more than 15,000 patients to date and is working with more than 1,800 physicians nationwide. The physician simply faxes his/her prescription to ASL® and ASL® does the rest. The patient's insurance is billed and the medications and devices ordered are then shipped directly to the patient's home. ASL® also provides patient education, which increases patient compliance. Given the enormous size of this patient population, ASL® has only scratched the surface in assisting physicians with treating chronic sinus disease. Therefore, ASL® is seeking additional physicians to help serve the larger population with chronic sinusitis.

Aerosol Science® Laboratories, Inc. dba ASL Pharmacy® is a privately held corporation with principal offices in Camarillo, CA.

Disclaimer: The NasoNeb™ Nasal Nebulizer is designed for use by a single person and is not to be shared with others, which could spread an infection. Close supervision is necessary when using a nebulizer on or near children or invalids. Safety instructions must be followed including not using this system in the presence of any flammable anesthetic mixture with air or with oxygen or nitrous oxide. The NasoNeb™ Nasal Nebulizer is available by prescription only.

For more information about the NasoNeb™ Nasal Nebulizer for the application of clarithromycin, liquid mupirocin, meropenem and other medications to chronic sinusitis sufferers, visit more Info.

Please direct all press inquiries to: Cal Tarrant 805-482-5555 x300

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/chronic_sinusitis/clarithromycin/prweb3917844.htm